WW International Reports Q2 Fiscal 2026 Results with $14.1M Net Income

WW International, Inc. reported its financial results for the second quarter of fiscal 2026, revealing a net income of $14.1 million, or $1.41 per diluted share, compared to a net income of $1.3 million for the same period in the previous year. The company generated total revenue of $162.3 million, a significant increase from $12.2 million in the prior year, although this figure is not directly comparable due to the company's emergence from bankruptcy in June 2025. The revenue decline from the previous fiscal period, which reported $177.0 million, was primarily attributed to a decrease in Behavioral Subscription Revenue, offset by growth in Clinical Subscription Revenue.

The company experienced a notable shift in its financial performance, with subscription revenue for the six months ending June 30, 2026, totaling $330.6 million, down from $363.6 million in the same period the previous year. The decline in Behavioral Subscription Revenue was linked to a lower number of Incoming Behavioral Subscribers, while Clinical Subscription Revenue saw an increase due to heightened consumer awareness and demand for new offerings. The gross profit margin for the quarter was 70.3%, down from 73.2% in the previous year, reflecting a mix shift towards Clinical subscriptions and increased depreciation expenses.

Operationally, WW International reported a total of 2.6 million subscribers at the end of the second quarter, a decrease from 3.4 million in the combined second quarter of fiscal 2025. The company noted a 25.4% decline in Incoming Behavioral Subscribers, while Clinical Subscribers increased significantly. The company has also been focusing on restructuring efforts, which included a reduction in workforce as part of its 2025 Plan, resulting in restructuring charges of $0.3 million for the first half of fiscal 2026.

In terms of liquidity, WW International had $101.5 million in unrestricted cash as of June 30, 2026, down from $160.3 million at the end of the previous fiscal year. The company reported a working capital surplus of $40.8 million, although it continues to face challenges in the competitive weight loss market, particularly with the rise of new weight-loss medications. Looking ahead, the company does not anticipate needing additional liquidity sources in the next 12 months, but it remains cautious about ongoing market disruptions and competitive pressures.

Overall, WW International's financial results reflect a complex transition period following its emergence from bankruptcy, with strategic shifts in its subscription offerings and ongoing efforts to stabilize its operations amid a challenging market landscape. The company is focused on leveraging its Clinical offerings to drive future growth while managing costs and restructuring its business model.